Search Results Search Sort by RelevanceMost Recent Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487. Case and Commentary Sep 2021 What Should Physician-Researchers Tell Patient-Subjects About Their Relationships With Industry? Jeffrey R. Botkin, MD, MPH Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research. AMA J Ethics. 2021;23(9):E685-691. doi: 10.1001/amajethics.2021.685. Medicine and Society Oct 2020 Racialization as a Barrier to Achieving Health Equity for Native Americans Vikas Gampa, MD, Kenneth Bernard, MD, MBA, and Michael J. Oldani, PhD, MS “Race” is a product of European-American views of phenotypic and cultural differences and continues to influence Native health decision making. AMA J Ethics. 2020;22(10):E874-881. doi: 10.1001/amajethics.2020.874. Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936. Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167. In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604. Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Next page Next › Last page Last »
Medicine and Society Jun 2021 Historical Trauma and Descendants’ Well-Being Reeya A. Patel, MS and Donna K. Nagata, PhD This article addresses intergenerational trauma transmission, focusing on Japanese American and Southeast Asian American communities. AMA J Ethics. 2021;23(6):E487-493. doi: 10.1001/amajethics.2021.487.
Case and Commentary Sep 2021 What Should Physician-Researchers Tell Patient-Subjects About Their Relationships With Industry? Jeffrey R. Botkin, MD, MPH Financial relationships are common, and ethical questions rightly emerge about how conflicts of interest compromise investigators’ approaches to research. AMA J Ethics. 2021;23(9):E685-691. doi: 10.1001/amajethics.2021.685.
Medicine and Society Oct 2020 Racialization as a Barrier to Achieving Health Equity for Native Americans Vikas Gampa, MD, Kenneth Bernard, MD, MBA, and Michael J. Oldani, PhD, MS “Race” is a product of European-American views of phenotypic and cultural differences and continues to influence Native health decision making. AMA J Ethics. 2020;22(10):E874-881. doi: 10.1001/amajethics.2020.874.
Case and Commentary Nov 2019 In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most? Andrea DiMartini, MD and Mary Amanda Dew, PhD Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research. AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
Original Research Feb 2019 Can AI Help Reduce Disparities in General Medical and Mental Health Care? Irene Y. Chen, Peter Szolovits, PhD, and Marzyeh Ghassemi, PhD As machine learning becomes increasingly common in health care, these systems’ data, algorithms, and recommendations raise critical justice questions. AMA J Ethics. 2019;21(2):E167-179. doi: 10.1001/amajethics.2019.167.
In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022;24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022;24(5):E376-381. doi: 10.1001/amajethics.2022.376.